Ilke Evrim Secinti

5PUBLICATIONS
9CO-AUTHORS
Cancer diagnosisHaematological tumoursPredictive and prognostic markersInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 18, 2026
Scrape versus imprint cytology in sentinel lymph nodes of breast cancer patients after neoadjuvant therapy: Does combination add value?

|Apr 06, 2026
The Importance of 5-hmC Expression Loss in Diagnosis of Mesothelioma and the Relationship Between TROP2 Expression and Histomorphological Parameters in Mesotheliomas.

Hale Kivrak, İlke Evrim Secinti, Egemen Akincioglu

|Aug 08, 2022
PD-L1 Expression in Colorectal Adenocarcinoma Is Associated With the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition.

Ilke Evrim Secinti, Tumay Ozgur, Isa Dede

|Jul 11, 2022
Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?

Ilke Evrim Secinti, Tumay Ozgur, Didar Gursoy

|Jul 30, 2020
Retinal teratogenicity of pregabalin in chick embryo model.

Ilke Evrim Secinti

Pageof 1

Frequent Collaborators

2 joint publications

Hale Kıvrak

2 joint publications

Egemen Akıncıoğlu

2 joint publications

Elcin Kadan

2 joint publications

Gülçin Şimşek